loading
Adial Pharmaceuticals Inc stock is traded at $0.3701, with a volume of 76,088. It is down -2.96% in the last 24 hours and up +5.74% over the past month. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.3814
Open:
$0.3742
24h Volume:
76,088
Relative Volume:
0.05
Market Cap:
$8.08M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.064
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
-7.82%
1M Performance:
+5.74%
6M Performance:
-47.87%
1Y Performance:
-61.04%
1-Day Range:
Value
$0.37
$0.38
1-Week Range:
Value
$0.364
$0.43
52-Week Range:
Value
$0.22
$1.30

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name
Name
Adial Pharmaceuticals Inc
Name
Phone
434-422-9800
Name
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Name
Employee
7
Name
Twitter
@AdialPharma
Name
Next Earnings Date
2024-12-12
Name
Latest SEC Filings
Name
ADIL's Discussions on Twitter

Compare ADIL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ADIL
Adial Pharmaceuticals Inc
0.3701 8.33M 0 -6.07M -7.34M -5.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.85 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.67 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.62 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
801.98 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.25 35.16B 4.56B -176.77M 225.30M -1.7177

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-24 Initiated Rodman & Renshaw Buy
Oct-30-18 Initiated Maxim Group Buy
Oct-11-18 Initiated Dawson James Buy

Adial Pharmaceuticals Inc Stock (ADIL) Latest News

pulisher
Oct 12, 2025

Using R and stats models for Adial Pharmaceuticals Inc. forecasting2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Relative strength of Adial Pharmaceuticals Inc. in sector analysisJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Should I hold or sell Adial Pharmaceuticals Inc. stock in 2025July 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com

Oct 12, 2025
pulisher
Oct 09, 2025

Adial completes key validation for alcohol disorder treatment test By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 09, 2025

Adial completes key validation for alcohol disorder treatment test - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution - GlobeNewswire

Oct 09, 2025
pulisher
Oct 09, 2025

100% SNP concordance: Adial and Genomind validate cheek‑swab test for AD04; AG+ biomarker ~14% - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Top chart patterns to watch in Adial Pharmaceuticals Inc.Gap Up & Smart Investment Allocation Insights - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Adial Pharmaceuticals Inc. benefit from macro trendsWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Nxera Pharma (OTCMKTS:SOLTF) and Adial Pharmaceuticals (NASDAQ:ADIL) Head to Head Survey - Defense World

Oct 07, 2025
pulisher
Oct 05, 2025

Why Adial Pharmaceuticals Inc. stock is a must watch in 2025Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What recovery options are there for Adial Pharmaceuticals Inc.July 2025 Gainers & Comprehensive Market Scan Reports - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Should you hold or exit Adial Pharmaceuticals Inc. nowJuly 2025 Update & AI Driven Stock Reports - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How moving averages guide Adial Pharmaceuticals Inc. tradingMarket Weekly Review & Daily Volume Surge Signals - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Maxim Group Upgrades Adial Pharmaceuticals (ADIL) - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga

Sep 30, 2025
pulisher
Sep 30, 2025

What drives Adial Pharmaceuticals Inc stock priceLong-Term Growth Stocks & High Profit Trading Signals - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Adial Pharmaceuticals (ADIL) Upgraded by Maxim Group | ADIL Stoc - GuruFocus

Sep 30, 2025
pulisher
Sep 20, 2025

Is Adial Pharmaceuticals Inc affected by consumer sentimentWeekly Earnings Recap & Daily Growth Stock Tips - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Dividend Watch: Is The First of Long Island Corporation showing insider buyingEntry Point & Real-Time Buy Zone Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Is Adial Pharmaceuticals Inc. stock bottoming outWatch List & Fast Moving Stock Trade Plans - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Why Adial Pharmaceuticals Inc. is moving todayMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Layoff Watch: Is Adial Pharmaceuticals Inc affected by consumer sentimentEarnings Beat & Growth Focused Stock Pick Reports - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

New Highs: What are Adial Pharmaceuticals Incs technical support levelsWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

RSI Check: Can Adial Pharmaceuticals Inc weather a recessionJuly 2025 Macro Moves & Fast Gain Swing Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Insider Buy: Will Canadian Solar Inc benefit from green energy policiesJuly 2025 Spike Watch & Low Volatility Stock Suggestions - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

What MACD and RSI say about Adial Pharmaceuticals Inc.Quarterly Risk Review & Weekly Return Optimization Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Profit Recap: Why is UMBF stock going up2025 Top Gainers & Safe Investment Capital Preservation Plans - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Stock Market Recap: How correlated is Nixxy Inc to the S P500Weekly Trade Summary & Growth Focused Stock Pick Reports - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Movement Recap: Will Barfresh Food Group Inc outperform the market in YEAR2025 Analyst Calls & Weekly Setup with High ROI Potential - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Volume: Is The Home Depot Inc.’s growth already priced inWeekly Trading Summary & AI Driven Stock Movement Reports - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Rate Hike: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Earnings & Verified Chart Pattern Signals - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Reversal indicators forming on Adial Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com

Sep 18, 2025
pulisher
Sep 18, 2025

Will a bounce in Adial Pharmaceuticals Inc. offer an exitIPO Watch & Long-Term Capital Growth Strategies - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Quarterly Recap: Is OPEN stock a hidden gemMarket Activity Recap & Weekly Breakout Watchlists - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Market Outlook: Can RITR outperform under higher oil pricesJuly 2025 Action & Fast Gaining Stock Reports - khodrobank.com

Sep 17, 2025
pulisher
Sep 16, 2025

Certain Stock Options of Adial Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 17-SEP-2025. - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Certain Common Stock of Adial Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 17-SEP-2025. - MarketScreener

Sep 16, 2025

Adial Pharmaceuticals Inc Stock (ADIL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.92
price up icon 3.07%
$83.54
price down icon 0.21%
$32.12
price up icon 1.01%
$102.47
price up icon 0.39%
$163.93
price up icon 0.51%
biotechnology ONC
$327.15
price up icon 2.24%
Cap:     |  Volume (24h):